If BPC-157 was purchased today, the patent would likely expire in 2033 before the phase 1-2-3 trials would be completed, at which point all the generic manufacturers would be able to push the product on the back of all the hard work a pharmaceutical company can do (Im not sure if FDA approval would push the expiration of the patent back, but even then it would not be so financial lucrative)
Well look at what its made of, its benefits, and how its used worldwide
This dual-peptide model has therefore become useful in laboratory studies examining musculoskeletal biology, connective tissue remodeling, and integrated tissue repair signaling systems
We prioritized compounds most frequently discussed across bodybuilding and sports-medicine sources
Injection-site reactions are among the most commonly reported side effects: patients may experience pain, stinging, or mild burning at the IM injection site
Products are tested for conductivity, endotoxin levels, clarity, pH, elemental contaminants, sterility, and fill volume conformity under controlled laboratory conditions